TwentyTwo
AI infrastructure for biosecurity
Founders
- Evan SeeyaveFounder/CEO
Same space
Competitors
Closest in what they build, same category.
Adjacent
Overlapping tags, a different niche.
EpinomaS21We engineer proteins that control the operating system of biology.Shared: synthetic biology, biotechActive
Pando BioscienceW23Gen-AI Designed Enzymes for Pharmaceutical InnovationShared: synthetic biology, biotechActive
Ansa BiotechnologiesW20Next-generation DNA synthesis using enzymesShared: synthetic biology, biotechActive
SynviviaS16Synvivia applies chemical control over cell behaviorShared: synthetic biology, biotechActive
ACXS24Next-generation biocides for sustainable agriculture at scaleShared: synthetic biology, biotechActive
Also from S25 in AI
Batchmates in Summer 2025.
AlterS25Secure access control and authorization platform for agent workflowsActive
ConvexiaS25The world's first AI-maximalist pharma companyActive
PangolinS25Open networking and security for your workforce, AI agents, and infraActive
PanoptiveS25The continuous oversight engine for clinical trialsActive
AcrelyS25Enterprise Voice AgentsActive
AdaptionalS25AI-powered insurance claims reviewActive
About TwentyTwo
AI is making biology easy to engineer. Life-saving drugs and therapies are accelerating, but so is the ability for bad actors to create a pandemic. TwentyTwo is working on the defensive stack to prevent the next pandemic.
New York City, NY, USA
TwentyTwo: questions
Which YC batch was TwentyTwo in?
TwentyTwo was in Y Combinator's Summer 2025 batch (S25).
Is TwentyTwo still active?
Y Combinator lists TwentyTwo as active.
Who founded TwentyTwo?
TwentyTwo's founders, as listed on its YC page: Evan Seeyave (Founder/CEO).
Where is TwentyTwo based?
TwentyTwo lists New York City, NY, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.